HealthDay on MSN5h
ASH: GLP-1 RA Use Tied to Lower Rate of Venous Thromboembolism in Diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
Daily1d
SGLT2 inhibitors linked to lower glaucoma risk, reveals research
A study published in the American Journal of Ophthalmology suggests that the use of SGLT2 inhibitors in diabetes is linked to ...
Hosted on MSN2d
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
A total of 20,146 patients with nephrolithiasis and type 2 diabetes, including those with gout at baseline, initiated an SGLT ...
Too Old to Operate3d
Lower Risk of Glaucoma with SGLT2i Treatment in Adults with Diabetes
The following is a summary of “Sodium-glucose cotransporter 2 inhibitors and glaucoma in patients with type 2 diabetes,” ...
Daily4d
Sitagliptin Improves Glycemic Control and Protect Kidneys in Adolescents with Type 1 Diabetes, New Study Finds
Egypt: A recent randomized controlled trial has demonstrated that sitagliptin, a DPP-4 inhibitor, significantly improves ...